Bongcheol
Bongcheol Kim, Gyeonggi-Do KR
Patent application number | Description | Published |
---|---|---|
20080248143 | Pulsatilla Spp. Extracts Effective in Brain Function - This invention relates to Pulsatillae Radix extract for improving brain functions. More specifically, this invention relates to Pulsatillae Radix extract, its active fractions and a pharmaceutical product and a health food containing the same respectively having a protective activity against neurotoxicity and a growth inhibitory effect induced by beta-amyloid, an anti-oxidizing effect, a neuron proliferating effect and improving memory thereby effective in improving brain functions such as Mild Cognitive Impairment and dementia. | 10-09-2008 |
20100298251 | WOUND-HEALING AGENT CONTAINING MOMORDICAE SEMEN EXTRACT - The present invention relates to Momordicae semen extract having wound-healing efficiencies. In particular, the present invention relates to a wound-healing topical transdermal agent comprising an active ingredient of Momordicae semen extract, which is capable of reducing the time required for the closure and treatment of wounds as confirmed in skin-wound induced animal model. | 11-25-2010 |
Bongcheol Kim, Seoul KR
Patent application number | Description | Published |
---|---|---|
20120276719 | METHODS OF FORMING SEMICONDUCTOR MEMORY DEVICES HAVING VERTICALLY STACKED MEMORY CELLS THEREIN - Methods of forming vertical nonvolatile memory devices utilize carbon-blocking sacrificial capping layers to increase device yield by reducing the likelihood that one or more vertically-stacked layers of materials will lift-off during fabrication. These capping layers may be provided to cover carbon-containing sacrificial layers that are highly polymerized. | 11-01-2012 |
Bongcheol Kim, Seongnam KR
Patent application number | Description | Published |
---|---|---|
20160108041 | SUBSTITUTED PYRIDINONE COMPOUNDS AS MEK INHIBITORS - The invention provides novel substituted heterocyclic compounds represented by Formula I and Formula II, or a pharmaceutically acceptable salt, solvate, polymorph, ester, tautomer or prodrug thereof, and a composition comprising these compounds. The compounds provided can be used as inhibitors of MEK and are useful in the treatment of inflammatory diseases, cancer and other hyperproliferative diseases. The invention further provides a method of treatment for inflammatory diseases, cancer and other hyperproliferative diseases in mammals, especially humans. | 04-21-2016 |